Key facts
- It has raised $13.7M; the latest was Later Stage VC ($8.0M) in Jul 2025.
- Notable investors include IMM Investment, Kiwoom Investment, Enlight Ventures, Comes Investment, Horizon Investment — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Microt
- ·The full record, as it builds
Funding rounds
No funding rounds for Microt are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Microt
Developer of glaucoma implants designed to control eye disease and intraocular pressure. The company's product reduces the difficulty in operations with micro-sized glaucoma implant devices and gel to protect damaged skin, enabling surgeons with accurate and efficient surgery.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 29
- Website
- microtinc.com/
- Ownership
- Privately Held (backing)
Microt doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Microt shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Microt in its N-PORT filings yet. We sweep new filings monthly.